<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="rapid-communication">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">HxbJSDn5hjDCQZwvKF4L9HC</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2012000100013</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(12)09800113</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012000100013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Comunica&#231;&#227;o Breve</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>&#205;ndice tornozelo-braquial e hipertrofia ventricular na hipertens&#227;o arterial</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Albuquerque</surname>
            <given-names>Pedro Ferreira de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albuquerque</surname>
            <given-names>Pedro Henrique Oliveira de</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albuquerque</surname>
            <given-names>Gustavo Oliveira de</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Servantes</surname>
            <given-names>Denise Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>Saskya Meneses de</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira Filho</surname>
            <given-names>Japy Angelini</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Macei&#243;</named-content>
          <named-content content-type="state">Alagoas</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual de Ci&#234;ncias da Sa&#250;de de Alagoas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">Macei&#243;</named-content>
          <named-content content-type="state">AL</named-content>
        </addr-line>
        <institution content-type="orgname">Cl&#237;nica do Cora&#231;&#227;o LTDA</institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Escola Paulista de Medicina </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2012</year>
      </pub-date>
      <volume>98</volume>
      <issue>1</issue>
      <fpage>84</fpage>
      <lpage>86</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>06</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>08</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>20</day>
          <month>07</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>O &#205;ndice Tornozelo-Braquial (ITB) &#233; marcador de doen&#231;a arterial obstrutiva perif&#233;rica. Raros relatos correlacionam esse &#237;ndice com hipertrofia ventricular esquerda (HVE), capacidade funcional (CF) e escore de risco coronariano de Framingham (ERCF). O objetivo do trabalho foi verificar a correla&#231;&#227;o entre ITB, HVE, CF e ERCF em homens com hipertens&#227;o arterial (HA). Estudo prospectivo e transversal de pacientes do sexo masculino (n = 40), com idade m&#233;dia de 57,92 &#177; 7,61 anos, sem complica&#231;&#245;es cardiovasculares. Essa popula&#231;&#227;o foi submetida &#224;s medidas de ITB, ecocardiograma (ECO), teste ergom&#233;trico (TE) e exames laboratoriais. O ITB (direito e esquerdo) foi considerado anormal quando a rela&#231;&#227;o entre a maior m&#233;dia das press&#245;es sist&#243;licas dos tornozelos e dos bra&#231;os foi inferior ou igual a 0,9 ou superior a 1,3 mmHg. A HVE foi identificada pelo ECO transtor&#225;cico; e a CF, pelo TE. Amostras sangu&#237;neas perif&#233;ricas foram colhidas para o c&#225;lculo do ERCF. Valores normais de ITB foram encontrados em 33 pacientes (82,5%), os quais foram inclu&#237;dos no Grupo I; sete pacientes (17,5%) com ITB anormal constitu&#237;ram o Grupo II. Os &#237;ndices de massa do &#237;ndice de massa do ventr&#237;culo esquerdo (IMVE) ao ECO foram de 111,18 &#177; 34,34 g/m&#178; (Grupo I) e de 150,29 &#177; 34,06 g/m2 (Grupo II) (p = 0,009). A preval&#234;ncia de HVE foi de 4% (Grupo I) e de 35,3% (Grupo II) (p = 0,01), constatando-se diferen&#231;as significativas entre os grupos. Quanto &#224; CF no TE, n&#227;o se registrou diferen&#231;a entre os grupos. Em rela&#231;&#227;o ao ERCF, a m&#233;dia do Grupo I foi inferior &#224; m&#233;dia do Grupo II: 13,18 &#177; 2,11 versus 15,28&#177;1,79 (p = 0,019). Em HA, a presen&#231;a de HVE definida pelo IMVE esteve mais presente nos casos com ITB anormal, identificando maior risco cardiovascular.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>&#205;ndice tornozelo bra&#231;o</kwd>
        <kwd>hipertrofia ventricular esquerda</kwd>
        <kwd>hipertens&#227;o</kwd>
        <kwd>medi&#231;&#227;o de risco</kwd>
        <kwd>fatores de risco</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>08</day>
        <month>02</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>COMUNICA&#199;&#195;O BREVE</bold>
    </p>
    <p>
      <bold>&#205;ndice tornozelo-braquial e hipertrofia ventricular na hipertens&#227;o arterial</bold>
    </p>
    <p>
      <bold>Pedro Ferreira de Albuquerque<sup>I</sup>; Pedro Henrique Oliveira de Albuquerque<sup>III</sup>; Gustavo Oliveira de Albuquerque<sup>III</sup>; Denise Maria Servantes<sup>III</sup>; Saskya Meneses de Carvalho<sup>III</sup>; Japy Angelini Oliveira Filho<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Universidade Estadual de Ci&#234;ncias da Sa&#250;de de Alagoas, UNCISAL, Macei&#243;, AL</p>
    <p><sup>II</sup>Universidade Federal de S&#227;o Paulo - Escola Paulista de Medicina, S&#227;o Paulo, SP</p>
    <p><sup>III</sup>Cl&#237;nica do Cora&#231;&#227;o LTDA, Macei&#243;, AL, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p>O &#205;ndice Tornozelo-Braquial (ITB) &#233; marcador de doen&#231;a arterial obstrutiva perif&#233;rica. Raros relatos correlacionam esse &#237;ndice com hipertrofia ventricular esquerda (HVE), capacidade funcional (CF) e escore de risco coronariano de Framingham (ERCF).</p>
    <p> O objetivo do trabalho foi verificar a correla&#231;&#227;o entre ITB, HVE, CF e ERCF em homens com hipertens&#227;o arterial (HA).</p>
    <p> Estudo prospectivo e transversal de pacientes do sexo masculino (n = 40), com idade m&#233;dia de 57,92 &#177; 7,61 anos, sem complica&#231;&#245;es cardiovasculares. Essa popula&#231;&#227;o foi submetida &#224;s medidas de ITB, ecocardiograma (ECO), teste ergom&#233;trico (TE) e exames laboratoriais. O ITB (direito e esquerdo) foi considerado anormal quando a rela&#231;&#227;o entre a maior m&#233;dia das press&#245;es sist&#243;licas dos tornozelos e dos bra&#231;os foi inferior ou igual a 0,9 ou superior a 1,3 mmHg. A HVE foi identificada pelo ECO transtor&#225;cico; e a CF, pelo TE. Amostras sangu&#237;neas perif&#233;ricas foram colhidas para o c&#225;lculo do ERCF.</p>
    <p> Valores normais de ITB foram encontrados em 33 pacientes (82,5%), os quais foram inclu&#237;dos no Grupo I; sete pacientes (17,5%) com ITB anormal constitu&#237;ram o Grupo II. Os &#237;ndices de massa do &#237;ndice de massa do ventr&#237;culo esquerdo (IMVE) ao ECO foram de 111,18 &#177; 34,34 g/m<sup>2</sup> (Grupo I) e de 150,29 &#177; 34,06 g/m2 (Grupo II) (p = 0,009). A preval&#234;ncia de HVE foi de 4% (Grupo I) e de 35,3% (Grupo II) (p = 0,01), constatando-se diferen&#231;as significativas entre os grupos. Quanto &#224; CF no TE, n&#227;o se registrou diferen&#231;a entre os grupos. Em rela&#231;&#227;o ao ERCF, a m&#233;dia do Grupo I foi inferior &#224; m&#233;dia do Grupo II: 13,18 &#177; 2,11 <italic>versus</italic> 15,28&#177;1,79 (p = 0,019).</p>
    <p> Em HA, a presen&#231;a de HVE definida pelo IMVE esteve mais presente nos casos com ITB anormal, identificando maior risco cardiovascular.</p>
    <p><bold>Palavras-chave:</bold> &#205;ndice tornozelo bra&#231;o, hipertrofia ventricular esquerda, hipertens&#227;o, medi&#231;&#227;o de risco, fatores de risco.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>As doen&#231;as cardiovasculares (DCV) representam importante impacto na morbimortalidade. Sendo assim, a preven&#231;&#227;o de eventos, incluindo a acurada identifica&#231;&#227;o dos fatores de risco, permanece um desafio para a sa&#250;de p&#250;blica<sup>1</sup>. Portanto, considera-se indispens&#225;vel identificar esses fatores, selecionando a popula&#231;&#227;o de risco, bem como se torna essencial o diagn&#243;stico da hipertrofia ventricular esquerda (HVE) e da doen&#231;a arterial obstrutiva perif&#233;rica (DAOP). A DAOP pode ser avaliada pelo &#205;ndice Tornozelo-Braquial (ITB)<sup>2</sup>.</p>
    <p>
      <bold>Objetivo</bold>
    </p>
    <p>Os objetivos deste estudo foram avaliar os valores do ITB em portadores de hipertens&#227;o arterial (HA) e correlacionar essas taxas com a presen&#231;a de HVE detectada pelo ecocardiograma (ECO), com a avalia&#231;&#227;o da capacidade funcional pelo teste ergom&#233;trico (TE) e com o risco cardiovascular estimado pelo escore de risco coronariano de Framingham (ERCF).</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Em estudo prospectivo e transversal, aprovado pelo Comit&#234; de &#201;tica em Pesquisa em Seres Humanos, da Universidade Estadual de Alagoas, entre dezembro de 2007 e julho de 2008, avaliaram-se 40 homens assintom&#225;ticos, com idade m&#233;dia de 57,95 &#177; 7,61 anos, portadores de HA, sem antecedentes cardiovasculares, doen&#231;a renal e diabete melito. Esses pacientes foram submetidos &#224;s medidas do ITB direito e esquerdo, ao ECO, ao TE e &#224; coleta de sangue perif&#233;rico. Para a obten&#231;&#227;o do ITB, foram tomadas as press&#245;es sist&#243;licas em art&#233;rias braquiais, pediosas e tibiais posteriores, considerando-se, para o c&#225;lculo, a m&#233;dia de duas press&#245;es tomadas em cada art&#233;ria. Utilizou-se a t&#233;cnica auscultat&#243;ria mediada por um Doppler Ultrassom Vascular 4283 DV 2001 (MEDPEJ, Ribeir&#227;o Preto, Brasil), com transdutor de 5 a 10 MHZ. O ITB (direito e esquerdo) foi considerado anormal quando a rela&#231;&#227;o entre a maior m&#233;dia das press&#245;es sist&#243;licas nos tornozelos e nos bra&#231;os foi inferior ou igual a 0,9 ou superior a 1,3 mmHg. A HVE foi definida pelo &#237;ndice de massa do ventr&#237;culo esquerdo (IMVE) superior a 115g/m<sup>2</sup> ao ECO transtor&#225;cico - aparelho Esaote Caris 2D com transdutor de 2,5 a 3,5 MHZ. A CF foi considerada pelo tempo m&#225;ximo de exerc&#237;cio alcan&#231;ado no TE, em minutos, utilizando-se o protocolo de Bruce em esteira rolante. Para o c&#225;lculo do ERCF, foram colhidas amostras de sangue perif&#233;rico ap&#243;s jejum de dez a doze horas, utilizando-se um Kit Olympus - aparelho Olympus AV 400 pelo m&#233;todo direto.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Para as vari&#225;veis num&#233;ricas, foram utilizados a m&#233;dia e o desvio padr&#227;o, j&#225; para as categ&#243;ricas usaram-se percentagens. Para as an&#225;lises de m&#233;dia dos grupos, empregou-se o Kruskal-Wallis H (<italic>equivalent to chi-square</italic>), enquanto para as categ&#243;ricas optou-se pela an&#225;lise de risco (<italic>odds ratio</italic>) ou pelo teste exato de Fisher, segundo as possibilidades. O n&#237;vel de signific&#226;ncia estat&#237;stica foi de 0,05.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Encontraram-se valores normais de ITB em 33 pacientes (82,5%), os quais foram inclu&#237;dos no Grupo I, ao passo que sete pacientes (17,5%) com ITB anormal constitu&#237;ram o Grupo II. O IMVE foi de 111,18 &#177; 34,34 g/m<sup>2</sup>, para o Grupo I, e de 150,29 &#177; 34,06 g/m<sup>2</sup>, para o Grupo II (p = 0,009) (<xref ref-type="fig" rid="a13graf01m">Gr&#225;fico 1</xref>).A preval&#234;ncia de HVE foi de 4% (Grupo I) e de 35,3% (Grupo II) (p = 0,01), com diferen&#231;as significativas (<xref ref-type="table" rid="a13tab01m">Tabela 1</xref>). Quanto &#224; CF, n&#227;o se registrou diferen&#231;a entre os grupos. Em rela&#231;&#227;o ao ERCF, a m&#233;dia do Grupo I foi inferior &#224; m&#233;dia do Grupo II: 13,18&#177;2,11 <italic>versus</italic> 15,28&#177;1,79 (p = 0,019).</p>
    <p content-type="asset">
      <fig id="a13graf01m">
        <graphic xlink:href="1678-4170-abc-98-01-0084-00013-gf01.jpg"/></fig>
    </p>
    <p content-type="asset">
      <table-wrap id="a13tab01m">
        <graphic xlink:href="1678-4170-abc-98-01-0084-00013-gt01.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Neste relato, a ocorr&#234;ncia de ITB anormal esteve associada &#224; HVE em pacientes hipertensos, sem complica&#231;&#245;es cardiovasculares. Relatos na literatura demonstram a influ&#234;ncia dos valores encontrados no ITB sobre a fun&#231;&#227;o ventricular esquerda e as altera&#231;&#245;es morfol&#243;gicas, constituindo um preditor independente de anormalidades ecocardiogr&#225;ficas. A presen&#231;a de ITB anormal tem alta preval&#234;ncia de disfun&#231;&#227;o do ventr&#237;culo esquerdo (VE) (fra&#231;&#227;o de eje&#231;&#227;o inferior a 45%) e est&#225; associada &#224; alta mortalidade cardiovascular<sup>3</sup>. Utilizando-se ecocardiografia de estresse, relatou-se que o ITB foi um forte indicador de mortalidade por todas as causas<sup>4</sup>. Outros relatos mostram a correla&#231;&#227;o inversa entre a massa do VE e o ITB, associando a disfun&#231;&#227;o do VE a valores reduzidos de ITB<sup>5</sup>. Em nosso estudo, a correla&#231;&#227;o inversa entre o ITB e a massa do VE foi significante: a m&#233;dia do IMVE foi de 111,18 &#177; 34,34 g/m<sup>2</sup>, para ITB normais, e de 150,29&#177;34,06 g/m<sup>2</sup>, para os anormais. &#201; poss&#237;vel que a maior rigidez vascular presente promova uma HVE compensat&#243;ria. No presente estudo, tamb&#233;m observamos uma associa&#231;&#227;o entre baixos valores de ITB e valores mais elevados do ERCF. Essa inversa propor&#231;&#227;o constitui uma combina&#231;&#227;o de risco para eventos cardiovasculares<sup>6</sup>.</p>
    <p>
      <bold>Limita&#231;&#245;es do estudo</bold>
    </p>
    <p>A despeito de constatar associa&#231;&#227;o entre redu&#231;&#245;es do ITB e preval&#234;ncia de HVE na HA, o presente estudo piloto utilizou casu&#237;stica reduzida (n = 40), avaliada em delineamento transversal. Ser&#227;o &#250;teis novos estudos longitudinais, envolvendo maiores amostras.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Em pacientes portadores de hipertens&#227;o arterial, sem manifesta&#231;&#245;es cl&#237;nicas de DAOP, os valores de ITB abaixo do limite de refer&#234;ncia associaram-se &#224; presen&#231;a de HVE, identificando os indiv&#237;duos de maior risco cardiovascular. Pacientes hipertensos com ITB anormal deveriam submeter-se &#224;s avalia&#231;&#245;es estruturais do VE.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Pedro Ferreira de Albuquerque pela Universidade Estadual de Alagoas - UNCISAL e UNIFESP/EPM -SP.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Pedro Ferreira de Albuquerque</p>
        <p> Av. Alvaro Otacilio, 6883 / Apto 304 - Edf. Residence de Louvres, Jatiuca</p>
        <p> 57036-850 - Macei&#243;, AL, Brasil</p>
        <p> E-mail: </p>
        <p><email xlink:href="pfalbuquerque@cardiol.br">pfalbuquerque@cardiol.br</email>, </p>
        <p>
          <email xlink:href="pfalbuquerque@uol.com.br">pfalbuquerque@uol.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 05/06/11; revisado recebido em 20/07/11; aceito em 23/08/11.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Greenland P, Smith SC, Grund SM. Improving coronary heart disease risk assessment, in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104(15):1863-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Improving coronary heart disease risk assessment, in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1863</fpage>
          <lpage>7</lpage>
          <issue>15</issue>
          <volume>104</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Greenland</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Grund</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 1997;131(1):115-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study</article-title>
          <source>Atherosclerosis</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>115</fpage>
          <lpage>25</lpage>
          <issue>1</issue>
          <volume>131</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Sharrett</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Chambless</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Rosamond</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Nieto</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Sheps</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Ward RP, Goonewardena SN, LammertinG, Lang RM. Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease. Am J Cardiol. 2007;99(4):499-503.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>499</fpage>
          <lpage>503</lpage>
          <issue>4</issue>
          <volume>99</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ward</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Goonewardena</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>LammertinG</surname>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Thatipelli MR, Pellikka PA, McBane RD, Rooke TW, Rosales GA, Hodge D, et al. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg. 2007;46(1):62-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>62</fpage>
          <lpage>70</lpage>
          <issue>1</issue>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thatipelli</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Pellikka</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>McBane</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Rooke</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Rosales</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Hodge</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Maldonado J, Pereira T, Resende M, Sim&#245;es D, Carvalho M. Usefulness of the ankle-brachial index in assessing vascular function in normal individuals. Rev Port Cardiol. 2008;27(4):465-76.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Usefulness of the ankle-brachial index in assessing vascular function in normal individuals</article-title>
          <source>Rev Port Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>465</fpage>
          <lpage>76</lpage>
          <issue>4</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maldonado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Resende</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sim&#245;es</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Fowkes FGR, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless AR, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197-208.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis</article-title>
          <source>JAMA</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>197</fpage>
          <lpage>208</lpage>
          <issue>2</issue>
          <volume>300</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fowkes</surname>
              <given-names>FGR</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Butcher</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Heald</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Chambless</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">&#205;ndice tobillo-braquial y hipertrofia ventricular en la hipertensi&#243;n arterial</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>El &#205;ndice Tobillo-Braquial (ITB) es un marcador de enfermedad arterial obstructiva perif&#233;rica. Raros relatos correlacionan ese &#237;ndice con la hipertrofia ventricular izquierda (HVI), capacidad funcional (CF) y puntaci&#243;n de riesgo coronario de Framingham (PRCF). El objetivo de este estudio fue verificar la correlaci&#243;n entre ITB, HVI, CF y PRCF en hombres con hipertensi&#243;n arterial (HA). Estudio prospectivo y transversal de pacientes del sexo masculino (n = 40), con edad promedio de 57,92 &#177; 7,61 a&#241;os, sin complicaciones cardiovasculares. Esa poblaci&#243;n fue sometida a las medidas de ITB, ecocardiograma (ECO), test ergom&#233;trico (TE) y ex&#225;menes de laboratorio. El ITB (derecho e izquierdo), se consider&#243; anormal cuando la relaci&#243;n entre la mayor media de las presiones sist&#243;licas de los tobillos y de los brazos fue inferior o igual a 0,9 o superior a 1,3 mmHg. La HVI fue identificada por el ECO transtor&#225;cico; y la CF por el TE. Muestras sangu&#237;neas perif&#233;ricas se recogieron para el c&#225;lculo del PRCF. Valores normales de ITB fueron encontrados en 33 pacientes (82,5%), los cuales se incluyeron en el Grupo I; siete pacientes (17,5%) con ITB anormal formaron el Grupo II. Los &#237;ndices de masa del &#237;ndice de masa del ventr&#237;culo izquierdo (IMVI) al ECO fueron de 111,18 &#177; 34,34 g/m&#178; (Grupo I) y de 150,29 &#177; 34,06 g/m&#178; (Grupo II) (p = 0,009). La prevalencia de HVI fue de 4% (Grupo I) y de 35,3% (Grupo II) (p = 0,01), siendo comprobadas las diferencias significativas entre los grupos. En cuanto a la CF en el TE, no se registr&#243; ninguna diferencia entre los grupos. Con relaci&#243;n al PRCF, el promedio del Grupo I qued&#243; por debajo del promedio del Grupo II: 13,18 &#177; 2,11 versus 15,28&#177;1,79 (p = 0,019). En HA, la presencia de HVI definida por el IMVI estuvo m&#225;s presente en los casos con ITB anormal, identificando un mayor riesgo cardiovascular.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>&#205;ndice tobillo brazo</kwd>
        <kwd>hipertrofia ventricular izquierda</kwd>
        <kwd>hipertensi&#243;n</kwd>
        <kwd>medici&#243;n de riesgo</kwd>
        <kwd>factores de riesgo</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>COMUNICACI&#211;N BREVE</bold>
      </p>
      <p>
        <fn id="inicio-body2">
          <label>
            <bold>&#205;ndice tobillo-braquial y hipertrofia ventricular en la hipertensi&#243;n arterial</bold>
          </label>
          <p>
            <bold>Pedro Ferreira de Albuquerque<sup>I</sup>; Pedro Henrique Oliveira de Albuquerque<sup>III</sup>; Gustavo Oliveira de Albuquerque<sup>III</sup>; Denise Maria Servantes<sup>III</sup>; Saskya Meneses de Carvalho<sup>III</sup>; Japy Angelini Oliveira Filho<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Estadual de Ci&#234;ncias da Sa&#250;de de Alagoas, UNCISAL, Macei&#243;, AL</p>
      <p><sup>II</sup>Universidade Federal de S&#227;o Paulo - Escola Paulista de Medicina, S&#227;o Paulo, SP</p>
      <p><sup>III</sup>Cl&#237;nica do Cora&#231;&#227;o LTDA, Macei&#243;, AL, Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p>El &#205;ndice Tobillo-Braquial (ITB) es un marcador de enfermedad arterial obstructiva perif&#233;rica. Raros relatos correlacionan ese &#237;ndice con la hipertrofia ventricular izquierda (HVI), capacidad funcional (CF) y puntaci&#243;n de riesgo coronario de Framingham (PRCF).</p>
      <p> El objetivo de este estudio fue verificar la correlaci&#243;n entre ITB, HVI, CF y PRCF en hombres con hipertensi&#243;n arterial (HA).</p>
      <p> Estudio prospectivo y transversal de pacientes del sexo masculino (n = 40), con edad promedio de 57,92 &#177; 7,61 a&#241;os, sin complicaciones cardiovasculares. Esa poblaci&#243;n fue sometida a las medidas de ITB, ecocardiograma (ECO), test ergom&#233;trico (TE) y ex&#225;menes de laboratorio. El ITB (derecho e izquierdo), se consider&#243; anormal cuando la relaci&#243;n entre la mayor media de las presiones sist&#243;licas de los tobillos y de los brazos fue inferior o igual a 0,9 o superior a 1,3 mmHg. La HVI fue identificada por el ECO transtor&#225;cico; y la CF por el TE. Muestras sangu&#237;neas perif&#233;ricas se recogieron para el c&#225;lculo del PRCF.</p>
      <p> Valores normales de ITB fueron encontrados en 33 pacientes (82,5%), los cuales se incluyeron en el Grupo I; siete pacientes (17,5%) con ITB anormal formaron el Grupo II. Los &#237;ndices de masa del &#237;ndice de masa del ventr&#237;culo izquierdo (IMVI) al ECO fueron de 111,18 &#177; 34,34 g/m<sup>2</sup> (Grupo I) y de 150,29 &#177; 34,06 g/m2 (Grupo II) (p = 0,009). La prevalencia de HVI fue de 4% (Grupo I) y de 35,3% (Grupo II) (p = 0,01), siendo comprobadas las diferencias significativas entre los grupos. En cuanto a la CF en el TE, no se registr&#243; ninguna diferencia entre los grupos. Con relaci&#243;n al PRCF, el promedio del Grupo I qued&#243; por debajo del promedio del Grupo II: 13,18 &#177; 2,11 <italic>versus</italic> 15,28&#177;1,79 (p = 0,019).</p>
      <p> En HA, la presencia de HVI definida por el IMVI estuvo m&#225;s presente en los casos con ITB anormal, identificando un mayor riesgo cardiovascular.</p>
      <p><bold>Palabras clave:</bold> &#205;ndice tobillo brazo, hipertrofia ventricular izquierda, hipertensi&#243;n, medici&#243;n de riesgo, factores de riesgo.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Las enfermedades cardiovasculares (ECV) representan un importante impacto en la morbimortalidad. Por tanto, la prevenci&#243;n de eventos que incluyan la exacta identificaci&#243;n de los factores de riesgo, permanece siendo un reto para la salud p&#250;blica<sup>1</sup>. Por eso, consideramos indispensable que se identifiquen esos factores, seleccionando la poblaci&#243;n de riesgo, como tambi&#233;n es fundamental diagnosticar la hipertrofia ventricular izquierda (HVI) y la enfermedad arterial obstructiva perif&#233;rica (EAOP). La EAOP puede evaluarse por el &#205;ndice Tobillo-Braquial (ITB)<sup>2</sup>.</p>
      <p>
        <bold>Objetivo</bold>
      </p>
      <p>Los objetivos de este estudio fueron evaluar los valores del ITB en portadores de hipertensi&#243;n arterial (HA) y correlacionar esas tasas en presencia de la HVI detectada por el ecocardiograma (ECO), con la consiguiente evaluaci&#243;n de la capacidad funcional por el test ergom&#233;trico (TE) y con el riesgo cardiovascular estimado por la puntuaci&#243;n de riesgo coronario de Framingham (PRCF).</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>En un estudio prospectivo y transversal, aprobado por el Comit&#233; de &#201;tica en Investigaci&#243;n en Seres Humanos, de la <italic>Universidade Estadual de Alagoas</italic>, entre diciembre de 2007 y julio de 2008, fueron evaluados 40 hombres asintom&#225;ticos, con una edad promedio de 57,95 &#177; 7,61 a&#241;os, portadores de HA, sin antecedentes cardiovasculares, enfermedad renal y diabetes mellitus. Esos pacientes se sometieron a las medidas del ITB derecho e izquierdo, al ECO, al TE y a la recogida de sangre perif&#233;rica. Para la obtenci&#243;n del ITB, se tomaron las presiones sist&#243;licas en las arterias braquiales, pediosas y tibiales posteriores, considerando, para ese c&#225;lculo, el promedio de dos presiones tomadas en cada arteria. Se us&#243; la t&#233;cnica de auscultaci&#243;n por medio de un Doppler de Ultrasonido Vascular 4283 DV 2001 (MEDPEJ, Ribeir&#227;o Preto, Brasil), con transductor de 5 a 10 MHZ. El ITB (derecho e izquierdo), fue considerado anormal cuando la relaci&#243;n entre el mayor promedio de las presiones sist&#243;licas en los tobillos y en los brazos fue inferior o igual al 0,9 o superior a 1,3 mmHg. La HVI se defini&#243; por el &#237;ndice de masa del ventr&#237;culo izquierdo (IMVI) superior a 115g/m<sup>2 </sup>al ECO transtor&#225;cico (aparato Esaote Caris 2D con transductor de 2,5 a 3,5 MHZ). La CF fue considerada por el tiempo m&#225;ximo de ejercicio alcanzado en el TE, en minutos, utilizando el protocolo de Bruce en una cinta sin fin. Para el c&#225;lculo del PRCF, se recogieron muestras de sangre perif&#233;rica despu&#233;s de un ayuno de diez a doce horas, utiliz&#225;ndose un Kit Olympus (aparato Olympus AV 400) por el m&#233;todo directo.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Para las variables num&#233;ricas, fueron utilizados el promedio y la desviaci&#243;n est&#225;ndar, ya que para las categ&#243;ricas se usaron los porcentajes. Para los an&#225;lisis de promedio de los grupos, se us&#243; el Kruskal-Wallis H (<italic>equivalent to chi-square</italic>), mientras que para las categ&#243;ricas se opt&#243; por el an&#225;lisis de riesgo (<italic>odds ratio</italic>) o por el test exacto de Fisher, seg&#250;n las posibilidades. El nivel de significancia estad&#237;stica fue de 0,05.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Hallamos valores normales de ITB en 33 pacientes (82,5%), que fueron incluidos en el Grupo I, mientras que siete pacientes (17,5%) con ITB anormal conformaron el Grupo II. El IMVI fue de 111,18 &#177; 34,34 g/m<sup>2</sup>, para el Grupo I, y de 150,29 &#177; 34,06 g/m<sup>2</sup>, para el Grupo II (p = 0,009) (<xref ref-type="fig" rid="es_a13graf01-body2">Gr&#225;fico 1</xref>). La prevalencia de HVI fue de un 4% (Grupo I) y de un 35,3% (Grupo II) (p = 0,01), con diferencias significativas (<xref ref-type="table" rid="es_a13tab01-body2">Tabla 1</xref>). En cuanto a la CF, no se registr&#243; ninguna diferencia entre los grupos. Con relaci&#243;n al PRCF, el promedio del Grupo I fue inferior al promedio del Grupo II: 13,18&#177;2,11 <italic>versus</italic> 15,28&#177;1,79 (p = 0,019).</p>
      <p content-type="asset">
        <fig id="es_a13graf01-body2">
          <graphic xlink:href="1678-4170-abc-98-01-0084-00013-gf01-es.jpg"/></fig>
      </p>
      <p content-type="asset">
        <table-wrap id="es_a13tab01-body2">
          <graphic xlink:href="1678-4170-abc-98-01-0084-00013-gt01-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>En este relato, el aparecimiento de ITB anormal estuvo asociado a la HVI en pacientes hipertensos sin complicaciones cardiovasculares. Relatos en la literatura demuestran la influencia de los valores encontrados en el ITB sobre la funci&#243;n ventricular izquierda y las alteraciones morfol&#243;gicas, constituyendo un predictor independiente de anormalidades ecocardiogr&#225;ficas. La presencia de ITB anormal tiene una alta prevalencia de disfunci&#243;n del ventr&#237;culo izquierdo (VI) (fracci&#243;n de eyecci&#243;n inferior al 45%), y est&#225; asociada a la alta mortalidad cardiovascular<sup>3</sup>. Utilizando la ecocardiograf&#237;a del estr&#233;s, se comprob&#243; que el ITB fue un fuerte indicador de mortalidad por todas las causas<sup>4</sup>. Otros relatos demuestran la correlaci&#243;n inversa entre la masa del VI y el ITB, asociando la disfunci&#243;n del VI a los valores reducidos de ITB<sup>5</sup>. En nuestro estudio, la correlaci&#243;n inversa entre el ITB y la masa del VI fue significativa: el promedio del IMVI fue de 111,18 &#177; 34,34 g/m<sup>2</sup>, para ITB normales, y de 150,29&#177;34,06 g/m<sup>2</sup>, para los anormales. Puede ser que la mayor rigidez vascular presente genere una HVI compensatoria. En el presente estudio, tambi&#233;n observamos una asociaci&#243;n entre los bajos valores de ITB y los valores m&#225;s elevados del PRCF. Esa proporci&#243;n inversa conforma una combinaci&#243;n de riesgo para eventos cardiovasculares<sup>6</sup>.</p>
      <p>
        <bold>Limitaciones del estudio</bold>
      </p>
      <p>Pese a constatar la asociaci&#243;n entre las reducciones del ITB y la prevalencia de HVI en la HA, el presente estudio piloto utiliz&#243; una casu&#237;stica reducida (n = 40), evaluada en un delineamiento transversal. Nuevos estudios longitudinales, que involucren m&#225;s muestras ser&#225;n muy bienvenidos.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>En los pacientes portadores de hipertensi&#243;n arterial, sin manifestaciones cl&#237;nicas de EAOP, los valores de ITB que est&#225;n por debajo del l&#237;mite de referencia, se asocian con la presencia de HVI, identificando los individuos de mayor riesgo cardiovascular. Los pacientes hipertensos con ITB anormal deber&#237;an someterse a las evaluaciones estructurales del VI.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuve fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de Disertaci&#243;n de Maestr&#237;a de Pedro Ferreira de Albuquerque, por la Universidade Estadual de Alagoas - UNCISAL e UNIFESP/EPM -SP.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Ankle-brachial index and ventricular hypertrophy in arterial hypertension</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>The ankle-brachial index (ABI) is a marker of peripheral arterial disease. Very few reports have correlated this index with left ventricular hypertrophy (LVH), functional capacity (FC) and Framingham risk score (FRS). The objective of this study was to verify the correlation between ABI, LVH, FC and FRS in men with arterial hypertension (AH). Prospective and cross-sectional study of male patients (n = 40) with a mean age of 57.92 &#177; 7.61 years and no cardiovascular complications. This population was submitted to ABI measurements, echocardiography (ECHO), exercise test (ET) and laboratory tests. The ABI (right and left) was considered abnormal when the ratio between the highest mean systolic pressures of the ankles and arms was 0.9 or higher than 1.3 mmHg. LVH was identified by transthoracic ECHO and the FC by the ET. Peripheral blood samples were collected to calculate the FRS. Normal ABI values were observed in 33 patients (82.5%), who were included in Group I; seven patients (17.5%) with abnormal ABI constituted Group II. Left ventricular mass index (LVMI) at the ECO were 111.18 &#177; 34.34 g/m2 (Group I) and 150.29 &#177; 34.06 g/m&#178; (Group II) (p = 0.009). The prevalence of LVH was 4% (Group I) and 35.3% (Group II) (p = 0.01), demonstrating a significant difference between the groups. As for the FC in ET, there was no difference between the groups. Regarding the FRS, the mean in Group I was below that in Group II: 13.18 &#177; 2.11 versus 15.28 &#177; 1.79 (p = 0.019). In hypertensive patients, the presence of LVH defined by the LVMI was more frequent in cases with abnormal ABI, identifying a higher cardiovascular risk.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Ankle brachial index</kwd>
        <kwd>hypertrophy, left ventricular</kwd>
        <kwd>hypertension</kwd>
        <kwd>risk assessment</kwd>
        <kwd>risk factors</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>BRIEF COMMENTS</bold>
      </p>
      <p>
        <fn id="inicio-body3">
          <label>
            <bold>Ankle-brachial index and ventricular hypertrophy in arterial hypertension</bold>
          </label>
          <p>
            <bold>Pedro Ferreira de Albuquerque<sup>I</sup>; Pedro Henrique Oliveira de Albuquerque<sup>III</sup>; Gustavo Oliveira de Albuquerque<sup>III</sup>; Denise Maria Servantes<sup>III</sup>; Saskya Meneses de Carvalho<sup>III</sup>; Japy Angelini Oliveira Filho<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Estadual de Ci&#234;ncias da Sa&#250;de de Alagoas, UNCISAL, Macei&#243;, AL</p>
      <p><sup>II</sup>Universidade Federal de S&#227;o Paulo - Escola Paulista de Medicina, S&#227;o Paulo, SP</p>
      <p><sup>III</sup>Cl&#237;nica do Cora&#231;&#227;o LTDA, Macei&#243;, AL, Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p>The ankle-brachial index (ABI) is a marker of peripheral arterial disease. Very few reports have correlated this index with left ventricular hypertrophy (LVH), functional capacity (FC) and Framingham risk score (FRS).</p>
      <p> The objective of this study was to verify the correlation between ABI, LVH, FC and FRS in men with arterial hypertension (AH).</p>
      <p> Prospective and cross-sectional study of male patients (n = 40) with a mean age of 57.92 &#177; 7.61 years and no cardiovascular complications. This population was submitted to ABI measurements, echocardiography (ECHO), exercise test (ET) and laboratory tests. The ABI (right and left) was considered abnormal when the ratio between the highest mean systolic pressures of the ankles and arms was 0.9 or higher than 1.3 mmHg. LVH was identified by transthoracic ECHO and the FC by the ET. Peripheral blood samples were collected to calculate the FRS.</p>
      <p> Normal ABI values were observed in 33 patients (82.5%), who were included in Group I; seven patients (17.5%) with abnormal ABI constituted Group II. Left ventricular mass index (LVMI) at the ECO were 111.18 &#177; 34.34 g/m<sup>2</sup> (Group I) and 150.29 &#177; 34.06 g/m<sup>2</sup> (Group II) (p = 0.009). The prevalence of LVH was 4% (Group I) and 35.3% (Group II) (p = 0.01), demonstrating a significant difference between the groups. As for the FC in ET, there was no difference between the groups. Regarding the FRS, the mean in Group I was below that in Group II: 13.18 &#177; 2.11 <italic>versus</italic> 15.28 &#177; 1.79 (p = 0.019).</p>
      <p> In hypertensive patients, the presence of LVH defined by the LVMI was more frequent in cases with abnormal ABI, identifying a higher cardiovascular risk.</p>
      <p><bold>Keywords:</bold> Ankle brachial index, hypertrophy, left ventricular, hypertension, risk assessment, risk factors.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Cardiovascular disease (CVD) has an important impact on morbimortality. Therefore, prevention of events, including the accurate identification of risk factors, remains a challenge for public health<sup>1</sup>. Thus, it is essential to identify these factors, selecting the population at risk, as well as to establish the diagnosis of left ventricular hypertrophy (LVH) and peripheral arterial disease (PAD), which can be assessed by ankle-brachial index (ABI)<sup>2</sup>.</p>
      <p>
        <bold>Objective</bold>
      </p>
      <p>The objectives of this study were to evaluate ABI values in patients with arterial hypertension (AH) and to correlate these values with the presence of LVH detected by echocardiography (ECHO), with the assessment of functional capacity by exercise test (ET) and the cardiovascular risk estimated by the Framingham risk score (FRS).</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The present is a prospective and cross-sectional study approved by the Ethics Committee in Human Research of Universidade Estadual de Alagoas, carried out between December 2007 and July 2008, which evaluated 40 asymptomatic men with a mean age of 57.95 &#177; 7.61 years, with AH and no history of cardiovascular or kidney disease and diabetes mellitus.</p>
      <p>The patients were submitted to right and left ABI measurements, ECO, ET and peripheral blood collection. To obtain the ABI, the systolic pressures were measured in the brachial, pedal and posterior tibial arteries, considering, for the calculation, the mean of two pressure measurements taken in each artery. We used the auscultatory technique mediated by a Doppler Vascular ultrasound 4283 DV 2001 (MEDPEJ, Ribeirao Preto, Brazil), with a 5 to 10 MHZ transducer. The ABI (right and left) was considered abnormal when the ratio between the highest mean of systolic pressures in the ankles and arms was <underline>&lt;</underline> 0.9 or &gt; 1.3 mmHg.</p>
      <p>LVH was defined by the left ventricular mass index (LVMI) &gt; 115g/m<sup>2</sup> at the transthoracic ECO, using an Esaote Caris 2D device with a 2.5 to 3.5 MHZ transducer. FC was considered by the maximal exercise time achieved at the ET in minutes, using the Bruce protocol on the treadmill. For the calculation of FRS, peripheral blood samples were collected after ten to twelve hour-fasting, using an Olympus Kit - Olympus AV 400 device, using the direct method.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Means and standard deviations were used for numeric variables and percentages were used for categorical ones. Kruskal-Wallis H test (equivalent to Chi-square test) was used for the analysis of group means, whereas for the categorical variables, risk analysis (odds ratio - OR) or Fisher's exact test were used as appropriate. Statistical significance level was set at 0.05.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Normal ABI values were observed in 33 patients (82.5%), which were included in Group I, while seven patients (17.5%) with abnormal ABI constituted Group II. The LVMI was 111.18 &#177; 34.34 g/m<sup>2</sup> in Group I and 150.29 &#177; 34.06 g/m<sup>2</sup>in Group II (p = 0.009) (<xref ref-type="fig" rid="en_a13chart01-body3">Chart 1</xref>). The prevalence of LVH was 4% (Group I) and 35.3% (Group II) (p = 0.01), with significant differences (<xref ref-type="table" rid="en_a13tab01-body3">Table 1</xref>). As for FC, there was no difference between the groups. Regarding FRS, the mean in Group I was below the mean in Group II: 13.18 &#177; 2.11 <italic>versus</italic> 15.28 &#177; 1.79 (p = 0.019).</p>
      <p content-type="asset">
        <fig id="en_a13chart01-body3">
          <graphic xlink:href="1678-4170-abc-98-01-0084-00013-gf01-en.jpg"/></fig>
      </p>
      <p content-type="asset">
        <table-wrap id="en_a13tab01-body3">
          <graphic xlink:href="1678-4170-abc-98-01-0084-00013-gt01-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>In this report, the occurrence of abnormal ABI was associated with LVH in hypertensive patients without cardiovascular complications. Reports in the literature have shown the influence of ABI values on left ventricular function and morphological alterations, constituting an independent predictor of echocardiographic abnormalities.</p>
      <p>The presence of abnormal ABI shows a high prevalence of left ventricular (LV) dysfunction (ejection fraction &lt; 45%) and is associated with high cardiovascular mortality<sup>3</sup>. Using stress echocardiography, it was reported that ABI was a strong predictor of mortality from all causes<sup>4</sup>. Other reports have shown an inverse correlation between LV mass and ABI, associating LV dysfunction to reduced ABI values<sup>5</sup>. In our study, the inverse correlation between ABI and LV mass was significant: the mean LVMI was 111.18 &#177; 34.34 g/m<sup>2</sup> for normal ABI, and 150.29 &#177; 34.06 g/m<sup>2</sup> for abnormal values. It is possible that the increased vascular stiffness promotes a compensatory LVH. In the present study, we also observed an association between low ABI values and higher values of FRS. This inverse proportion constitutes a risk combination for cardiovascular events<sup>6</sup>.</p>
      <p>
        <bold>Study limitations</bold>
      </p>
      <p>Although it demonstrated an association between ABI reductions and LVH prevalence in AH, this pilot study had a small sample size (n = 40), which was evaluated in a cross-sectional design. Future longitudinal studies with larger samples will be useful.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>In patients with arterial hypertension without clinical manifestations of PAD, ABI values below the reference limit were associated with the presence of LVH, identifying individuals at higher cardiovascular risk. Hypertensive patients with abnormal ABI should be submitted to LV structural assessment.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Pedro Ferreira de Albuquerque, from Universidade Estadual de Alagoas - UNCISAL e UNIFESP/EPM -SP.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
